# Use of Accelerometer for Quantification of Neurogenic Orthostatic Hypotension Symptoms

> **NCT04782830** · NA · RECRUITING · sponsor: **Vanderbilt University Medical Center** · enrollment: 29 (estimated)

## Conditions studied

- Orthostatic; Hypotension, Neurogenic
- Autonomic Failure
- Pure Autonomic Failure
- Multiple System Atrophy
- Orthostatic; Hypotension, Parkinsonism

## Interventions

- **DEVICE:** Accelerometer
- **DRUG:** placebo pill
- **DRUG:** Midodrine or atomoxetine pill

## Key facts

- **NCT ID:** NCT04782830
- **Lead sponsor:** Vanderbilt University Medical Center
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2021-02-05
- **Primary completion:** 2027-06-01
- **Final completion:** 2027-10-01
- **Target enrollment:** 29 (ESTIMATED)
- **Last updated:** 2025-06-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04782830

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04782830, "Use of Accelerometer for Quantification of Neurogenic Orthostatic Hypotension Symptoms". Retrieved via AI Analytics 2026-07-04 from https://api.ai-analytics.org/clinical/NCT04782830. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*